Good
Mostly Aligned
Patient Risk:
Moderate
Summary
Most pharmacokinetic and interaction claims are generally consistent with the label excerpts provided (e.g., Tmax 1–2 hours, grapefruit juice via CYP3A4, grapefruit quantity threshold, liver tests timing, response within 2 weeks/4 weeks). However, several claims are either unsupported by the provided label excerpts or potentially over-specified (e.g., 'fully absorbed within 1–2 hours', 'bioavailability ~14%', 'no extended-release version', generalized statements about older/liver-impaired absorption changes, and several non-Lipitor PK comparisons for other statins).
Category Scores
Accurate Statements
Lipitor reaches peak plasma concentrations about 1 to 2 hours after oral administration in fasted adults.
12.3 Pharmacokinetics: 'maximum plasma concentrations occur within 1 to 2 hours.'
Absorption of Lipitor is rapid.
12.3 Pharmacokinetics: Tmax within 1 to 2 hours supports 'rapid' characterization (timing consistent).
Food slightly delays Lipitor absorption, shifting peak concentrations to 2 to 3 hours.
Not assessable from provided excerpts; however label excerpt states LDL-C reduction is similar with/without food (12.3) and provides Tmax without explicit food effect. No direct support for '2 to 3 hours' from provided text.
Food does not reduce the overall extent of Lipitor absorption.
12.3: 'LDL-C reduction is similar whether LIPITOR is given with or without food.' (Note: this is about pharmacodynamic response, not explicitly 'extent of absorption').
Lipitor tablets are immediate-release.
3 Dosage Forms and Strengths: 'film-coated tablets containing 10, 20, 40, and 80 mg' (no explicit 'immediate-release' wording in provided excerpts).
Grapefruit juice can delay or reduce Lipitor absorption.
7.2 Grapefruit Juice: 'inhibit CYP3A4 and can increase plasma concentrations of atorvastatin' (interaction described).
Grapefruit juice delays or reduces Lipitor absorption by inhibiting metabolism or altering stomach pH.
7.2 indicates CYP3A4 inhibition increasing atorvastatin plasma concentrations; provided excerpt does not mention stomach pH or 'delay/reduce absorption'.
Certain antacids can delay or reduce Lipitor absorption.
Not supported by provided label excerpts (no antacid interaction text included).
Cholesterol reduction begins within 2 weeks of daily dosing of Lipitor.
14.2 Hyperlipidemia: 'Therapeutic response is seen within 2 weeks.'
Lipitor has full effects by 4 weeks.
14.2: 'maximum response usually achieved within 4 weeks.'
Steady-state plasma levels of Lipitor occur after 1 to 2 weeks.
Not assessable from provided excerpts (no steady-state timing text included).
Grapefruit juice delays or reduces Lipitor absorption by inhibiting metabolism or altering stomach pH.
7.2 supports CYP3A4 inhibition by grapefruit components; does not support 'delay or reduce' or 'stomach pH' in provided excerpts.
For rosuvastatin (Crestor), time to peak absorption in fasted conditions is 3 to 5 hours.
Not assessable; label excerpts only contain information for LIPITOR.
For simvastatin (Zocor), time to peak absorption in fasted conditions is 1.3 to 2.4 hours.
Not assessable; label excerpts only contain information for LIPITOR.
For pravastatin (Pravachol), time to peak absorption in fasted conditions is 1 to 1.5 hours.
Not assessable; label excerpts only contain information for LIPITOR.
Lipitor absorbs faster than rosuvastatin but similar to simvastatin and pravastatin.
Not assessable; relies on other statin PK values not present in provided LIPITOR label excerpts.
Unsupported Statements
Lipitor has bioavailability around 14% due to extensive first-pass metabolism in the liver.
No bioavailability percentage or '14%' first-pass metabolism statement in provided label excerpts (12.3 is about recovery in urine and Tmax, not bioavailability).
Lipitor is fully absorbed from the gastrointestinal tract within the 1 to 2 hour timeframe under normal conditions.
Label excerpt provides Tmax timing (12.3) but does not state 'fully absorbed' or 'within 1 to 2 hours' complete absorption.
Food slightly delays Lipitor absorption, shifting peak concentrations to 2 to 3 hours.
Provided 12.3 excerpt states Tmax occurs within 1 to 2 hours; it does not provide an alternate Tmax range with food.
Older patients or those with liver impairment may see slower absorption and lower peak levels of Lipitor.
Provided label excerpts do not include absorption speed/peak differences for older age or liver impairment.
No extended-release version of Lipitor exists.
Provided label excerpts do not address product formulation availability (no statement about XR vs IR).
Grapefruit juice delays or reduces Lipitor absorption by inhibiting metabolism or altering stomach pH.
7.2 supports CYP3A4 inhibition increasing plasma concentrations; it does not support 'delay or reduce absorption' nor 'altering stomach pH' in the excerpt.
Certain antacids can delay or reduce Lipitor absorption.
No antacid interaction information in provided label excerpts.
Certain antacids delay or reduce Lipitor absorption by inhibiting metabolism or altering stomach pH.
No antacid interaction or mechanism text in provided label excerpts.
Steady-state plasma levels of Lipitor occur after 1 to 2 weeks.
No steady-state timing statement included in provided label excerpts.
Lipitor's original patents expired in 2011 in the US, enabling generics.
No patent or exclusivity information in provided label excerpts.
No active patents block immediate-release absorption formulations of Lipitor.
No patent/exclusivity information in provided label excerpts.
For rosuvastatin (Crestor), time to peak absorption in fasted conditions is 3 to 5 hours.
Provided label excerpts contain only LIPITOR (atorvastatin) information; no rosuvastatin PK data.
For simvastatin (Zocor), time to peak absorption in fasted conditions is 1.3 to 2.4 hours.
Provided label excerpts contain only LIPITOR (atorvastatin) information; no simvastatin PK data.
For pravastatin (Pravachol), time to peak absorption in fasted conditions is 1 to 1.5 hours.
Provided label excerpts contain only LIPITOR (atorvastatin) information; no pravastatin PK data.
Lipitor absorbs faster than rosuvastatin but similar to simvastatin and pravastatin.
Relies on other statin PK values not provided in LIPITOR label excerpts.
Contradictions
Low
AI Statement
Grapefruit juice can delay or reduce Lipitor absorption.
Label Reference
7.2 Grapefruit Juice: 'can increase plasma concentrations of atorvastatin' (not delay/reduce).
Low
AI Statement
Grapefruit juice delays or reduces Lipitor absorption by inhibiting metabolism or altering stomach pH.
Label Reference
7.2 Grapefruit Juice: describes CYP3A4 inhibition increasing plasma concentrations; provided excerpt does not support 'delay/reduce absorption' nor stomach pH mechanism.
Important Omissions
No mention of contraindications (active liver disease, hypersensitivity, pregnancy, nursing) or key warnings/precautions (myopathy/rhabdomyolysis risk with certain concomitant drugs, liver function test schedule, etc.) despite multiple safety-relevant claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims about grapefruit and antacids/absorption and steady-state are unsupported or potentially directionally incorrect (e.g., grapefruit 'delay or reduce absorption' vs label indicating increased atorvastatin plasma concentrations). These inaccuracies could mislead expectations about drug exposure and interaction management.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Mostly Aligned
Primary Issue
Multiple unsupported or over-specific pharmacokinetic and interaction claims not present in the provided LIPITOR label excerpts (notably bioavailability %, 'fully absorbed', food effect on Tmax, older/liver impairment absorption changes, antacid interactions, steady-state timing, and grapefruit interaction direction).
Suggested Improvement
Restrict claims to label-supported statements in the provided excerpts: keep Tmax (1–2 hours), grapefruit interaction mechanism as CYP3A4 inhibition with increased plasma concentrations (and quantity threshold >1.2 L/day), and therapeutic response timeline (within 2 weeks; maximum usually by 4 weeks). Remove or qualify unsupported quantitative or cross-drug comparisons and avoid stating 'delay/reduce absorption' for grapefruit.